The Effect of Myofascial Release Exercises on Viscoelastic Changes of the Pectoralis Major Muscle, Pain, Range of Motion and Shoulder Functionality in Individuals Receiving Adjuvant Radiotherapy After Breast Cancer Surgery
1 other identifier
interventional
30
1 country
1
Brief Summary
Chemotherapy, hormone therapy and radiotherapy used in the treatment of breast cancer try to prevent the recurrence of cancer. In addition to the benefits of radiotherapy, such as a decrease in recurrence and an increase in long-term survival, it may have side effects that may affect the well-being and daily life activities of patients. One of the treatment modalities used to cope with treatment-related side effects is myofascial release exercises. Myofascial release exercises can help reduce adhesions caused by scar tissue and fibrosis caused by radiation. In the literature, there is no study investigating the effect of myofascial release exercises on pectoralis major muscle viscoelastic structure. For this purpose, our study aims to investigate the effect of myofascial release exercises performed in addition to home exercise programme on pectoralis major muscle viscoelastic structure, pain, range of motion and shoulder functionality.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable breast-cancer
Started Dec 2024
Shorter than P25 for not_applicable breast-cancer
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 20, 2024
CompletedFirst Submitted
Initial submission to the registry
January 2, 2025
CompletedFirst Posted
Study publicly available on registry
January 8, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 30, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
May 10, 2025
CompletedNovember 25, 2025
January 1, 2025
3 months
January 2, 2025
November 22, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Tone - pectoralis major
Myoton® PRO (Myoton Ltd, Myoton AS, Estonia) device will be used to objectively evaluate the measurement of Pectoralis Major muscle tone of the patients who will participate in the study. Myoton® PRO is a portable digital device that measures the tone with an objective and noninvasive method. A constant pre-pressure (0.18 N) is applied to the skin surface to compress the subcutaneous superficial tissues. The tension state of the tissue that characterized by the natural oscillation frequency; Hz.
6 weeks
Range of motion
Shoulder range of motion will be evaluated by digital goniometer. Shoulder flexion degree, shoulder extension degree, abduction and adduction degree, internal rotation and external rotation degree will be assessed with digital goniometer. The results will be recorded in degrees.
6 weeks
Secondary Outcomes (3)
Pain - Visual Analogue Scale
6 weeks
Shoulder Pain and Disability Index- SPADI
6 weeks
Quality of Life- Functional Assessment of Cancer Therapy-Breast" (FACT-B)
6 weeks
Study Arms (2)
home based exercise group
ACTIVE COMPARATORhome-based exercise 5 days a week
Myofascial release exercise group
EXPERIMENTALhome based exercise plus Myofascial release exercise
Interventions
Eligibility Criteria
You may qualify if:
- Stage I-II-III defined by radiation oncologists after breast cancer surgery and who will start radiotherapy
- Breast conserving surgery or total mastectomy with axillary lymph node dissection during surgery
- No neurological or orthopaedic problems that may limit the range of motion of the shoulder joint in the preoperative evaluations,
- Individuals who volunteer to participate in the study will be included.
You may not qualify if:
- Previous breast clamp surgery on the same side or contralateral side,
- With a metastatic cancer focus,
- Post-surgical resistance, infection and open wound, pacemaker,
- Patients with a Mini Mental State Examination test score of less than 21 will be excluded from the study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
SBU. Prof. Dr. Cemil Taşçıoğlu City Hospital- Oncology Clinic
Istanbul, Turkey (Türkiye)
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Asistant professor
Study Record Dates
First Submitted
January 2, 2025
First Posted
January 8, 2025
Study Start
December 20, 2024
Primary Completion
March 30, 2025
Study Completion
May 10, 2025
Last Updated
November 25, 2025
Record last verified: 2025-01